Medi-Caps Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Pharma Division: 81.5% • Real Estate Division: 18.5%
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Company is almost debt free
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.04x)
- Company generates healthy free cash flow
CONS
- Company is loss-making at the operating / net level
- Interest coverage is weak at -622.0x - earnings barely cover interest
- Recent results are weak - TTM profit is down 119.6% versus prior year
- Operating cash flow has been negative in recent years
- Company has a low return on capital employed of 2.6%
- Company has a low return on equity of 2.2% over last 3 years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SOLARINDS | 22307.50 | 101.37 | 201860.69 | 0.05 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| PIDILITIND | 1567.45 | 60.23 | 159547.55 | 1.37 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| SRF | 2483.00 | 34.05 | 73602.28 | 0.36 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| FLUOROCHEM | 4771.75 | 85.23 | 52417.67 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 9.58 | 26.83 |
| NAVINFLUOR | 8541.10 | 55.49 | 43822.77 | 0.18 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| GODREJIND | 1127.00 | 32.29 | 37963.11 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| AETHER | 1672.95 | 94.41 | 22204.70 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| DEEPAKNTR | 1587.10 | 27.64 | 21646.94 | 0.47 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| ATUL | 6244.55 | 23.11 | 18385.05 | 0.48 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| AARTIIND | 492.15 | 33.62 | 17851.59 | 0.20 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.95 | 16.00 |
| DEEPAKFERT | 1320.45 | 17.00 | 16725.20 | 0.76 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| MEDICAPQ | 31.75 | 0.00 | 39.59 | 0.00 | -2.23 | 36.05 | 2.79 | 3.99 | -2.58 | -65.73 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 2 | 3 | 2 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | |
| 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Operating Profit | -0 | 2 | 2 | 1 | -0 | 0 | -0 | 0 | -1 | 0 | 0 | -0 | -1 |
| OPM % | — | 92.42% | 70.81% | 49.46% | -146.43% | 38.54% | -132.00% | 22.73% | — | 32.00% | 23.38% | -72.55% | -564.76% |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | -0 | 2 | 2 | 1 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | -0 | -1 |
| Tax % | -0.00% | 0.00% | 21.03% | 42.98% | -0.00% | 0.00% | -0.00% | -61.36% | -0.00% | 0.00% | 9.68% | 3.03% | -0.00% |
| Net Profit | -0 | 2 | 2 | 1 | -0 | 0 | -0 | 1 | -0 | 0 | 0 | -0 | -1 |
| -0.31 | 1.55 | 1.35 | 0.52 | -0.27 | 0.36 | -0.21 | 0.57 | -0.32 | 0.23 | 0.23 | -0.25 | -0.47 |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 23 | 22 | 22 | 11 | 0 | 0 | 0 | 7 | 2 | 2 | 2 | |
| 22 | 22 | 22 | 20 | 0 | 1 | 0 | 2 | 3 | 3 | 3 | |
| Operating Profit | 1 | 0 | -0 | -9 | 0 | -1 | -0 | 5 | -0 | -1 | -0 |
| OPM % | 3.38% | 1.96% | -0.20% | -83.16% | — | — | -289.15% | 67.55% | -4.85% | -22.34% | -19.41% |
| 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | 2 | 1 | 1 | -8 | 0 | -0 | 0 | 5 | 0 | -0 | -0 |
| Tax % | 23.39% | 26.21% | 16.46% | -0.10% | — | -23.68% | -0.55% | 19.45% | -94.77% | -11.32% | -6.27% |
| Net Profit | 1 | 1 | 1 | -8 | 0 | -0 | 0 | 4 | 1 | -0 | -0 |
| EPS | 0.00 | 0.00 | 0.00 | -6.14 | -0.09 | -0.03 | 0.12 | 3.12 | 0.45 | -0.11 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- -21%
- 5 Years:
- —
- 3 Years:
- 183%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- 0%
- 5 Years:
- 1%
- 3 Years:
- 2%
- Last Year:
- 0%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| 54 | 54 | 55 | 47 | 48 | 49 | 49 | 54 | 55 | 54 | |
| Trade Payables | 2 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | 3 | 3 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | |
| Total Liabilities | 72 | 72 | 74 | 62 | 63 | 62 | 62 | 68 | 68 | 67 |
| 4 | 4 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | |
| 50 | 51 | 52 | 52 | 53 | 54 | 52 | 55 | 57 | 56 | |
| 8 | 6 | 7 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 4 | 3 | |
| Cash & Bank | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| 8 | 9 | 9 | 4 | 5 | 5 | 7 | 6 | 5 | 6 | |
| Total Assets | 72 | 72 | 74 | 62 | 63 | 62 | 62 | 68 | 68 | 67 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 1 | 1 | -1 | 2 | -1 | -3 | 3 | 2 | -0 | |
| Cash from Investing | -2 | -1 | -1 | -0 | -2 | 1 | 2 | -3 | -2 | 0 |
| Cash from Financing | 0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 0 | 0 | -1 | -0 | 0 | -1 | 0 | 0 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for MEDICAPQ
Loading news…
AI Stock Analyst
Medi-Caps Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account